Clinical trials
Every registered trial of Gonadorelin (GnRH)
366 studies, 56 still enrolling.
Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Gonadorelin (GnRH) has been studied in people a great deal.
- 366 registered studies in total.
- 56 are still enrolling people, so this is active research, not just history.
What kind of research
- 333 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 84,946 people took part in those.
- A further 33 studies only looked at records of people already taking it. These are counted separately because nobody was given the peptide for the study, so they cannot prove cause and effect.
How far along it is
- 130 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
- 95 have published results in the medical literature that anyone can read.
- The research spans 75 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 366 of 366 trials for Gonadorelin (GnRH).
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
University of Washington
Castration-Sensitive Prostate Adenocarcinoma · Metastatic Castration-Sensitive Prostate Adenocarcinoma · Stage IVB Prostate Cancer AJCC v8
BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder
University of Illinois at Chicago
Early-stage Breast Cancer · Hypoactive Sexual Desire Disorder · Hormone Receptor Positive Breast Carcinoma · Breast Cancer
Linzagolix in Adenomyosis and Recurrent Implantation Failure
Vida Fertility Institute
Adenomyosis of Uterus · Implantation Failure · Infertility Female · Embryo Transfer
A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer
Astellas Pharma Global Development, Inc.
Prostate Cancer
Purpose to Evaluate the Effectiveness of the Superovulation Stimulation Protocol Using Human Chorionic Gonadotropin (hCG) by Demonstrating Its Equivalence to Standard Controlled Ovarian Stimulation Protocols in Terms of Oocytes Retrieved, Blastulation While Maintaining an Economic Advantage
LTD "EKODNIPRO", Medical centre Medical Plaza Dnipro
Infertility (IVF Patients) · Infertility Assisted Reproductive Technology · Infertile Patients · Infertility Drugs
Effect of GnRH Agonist in FET
Assiut University
GnRH Agonist
PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC
West China Hospital
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
FET in Adenomyosis
Indira IVF Hospital Pvt Ltd
Adenomyosis
GnRH Agonist Pretreatment in Persistent Chronic Endometritis Undergoing FET
Guoxia Yang
Chronic Endometritis
Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients.
Fudan University
Breast Cancer
Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders
Bedaya Hospital
Infertility
Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A
ShangHai Ji Ai Genetics & IVF Institute
Preimplantation Genetic Testing · Progestin-primed Ovarian Stimulation · Polycystic Ovarian Syndrome · GnRH Antagonist
Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
University of Chicago
Elderly · Prostate Cancer
GnRH for Luteal Support - Mechanism of Action
Heli Alexandroni
GnRH Antagonist IVF Protocol · Fresh Embryo Transfer · Administration of Hormonal Luteal Support
Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
CHU de Quebec-Universite Laval
Reccurent/Metastatic Solid Tumor Disease · Prostate Cancer (Post Prostatectomy) · Prostate Cancer · Prostatic Neoplasms
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans
University of British Columbia
Cerebral Blood Flow · Cerebral Blood Flow Regulation · Sex Differences · Exercise
Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study
Zhongda Hospital
Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Prostate Cancer · Brachytherapy · Stereotactic Body Radiation Therapy (SBRT) · Dose Escalation: Solid Tumors
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Prostate Cancer (Adenocarcinoma) · Prostate Brachytherapy · Stereotactic Body Radiation Therapy (SBRT) · Dose Escalation: Solid Tumors
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Metastatic Castration-resistant Prostate Cancer
Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
H. Lee Moffitt Cancer Center and Research Institute
Metastatic Castration-resistant Prostate Cancer
A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Infertility
Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification
Fudan University
Endometrial Cancer · Fertility
Comparison of IVF Outcomes Between PPOS and Antagonist Protocols in Women With PCOS
Hanoi General Hospital (Vietnam)
Polycystic Ovary Syndrome (PCOS) · Female Infertility
Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer
National Taiwan University Hospital
In Vitro Fertilization (IVF) · Embryo Transfer
CSET 2025/4053
Institut Gustave Roussy
Breast cancer
IVM - Fresh ET (THE SAIGON PROTOCOL) Versus IVF - FET in PCOS Women
Mỹ Đức Hospital
Polycystic Ovary Syndrome (PCOS) · In Vitro Maturation of Oocytes · Fresh Embryo Transfer
The COSMYC Trial (COmbined Suppression of MYC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Metastatic Castration-resistant Prostate Cancer
GnRH Agonist Pretreatment Duration and Letrozole Supplementation in Frozen Embryo Transfer for Adenomyosis Patients
First Affiliated Hospital, Sun Yat-Sen University
Adenomyosis of Uterus · Frozen Embryo Transfer (FET)
Does The Addition Of Letrozole To Ultra-Long GnRH Agonists Help Adenomyosis Patients in ART? The AURA Trial
University of Palermo
Adenomyosis of Uterus · Infertility Assisted Reproductive Technology
Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer
OHSU Knight Cancer Institute
High Risk Prostate Carcinoma · Localized Prostate Adenocarcinoma · Stage I Prostate Cancer AJCC v8 · Stage II Prostate Cancer AJCC v8
Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
UNICANCER
High Risk Prostate Carcinoma · Prostate Cancer
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
University of Chicago
Triple Negative Breast Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Novartis Pharmaceuticals
Breast Neoplasms
Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Metastatic Castration Sensitive Prostate Cancer
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
MedSIR
Advanced Breast Cancer · ER-positive Breast Cancer · HER2-negative Breast Cancer · ESR1 Gene Mutation
Protocol with Progestin-primed Ovarian Stimulation (PPOS) in conventional treatment from the start of stimulation vs protocol with GnRH antagonists as a pituitary suppressor in patients who are going to undergo DUOSTIM with embryo accumulation for PGT-A of the embryos.
Ginefiv S.L.
Female infertility
Study on Human Bioequivalence of Triprerelin Acetate for Injection
The Affiliated Hospital of Qingdao University
Prostate Cancer (CRPC)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Amgen
Prostate Cancer
2019_0012
Hospital Foch
Endometriosis, adenomyosis
A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
Novartis Pharmaceuticals
Metastatic Castration-Resistant Prostate Cancer
A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer
R-Pharm International, LLC
Metastatic Castration-resistant Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Effect of Estradiol Pretreatment on Follicular Synchronization and IVF Outcomes in Women With Polycystic Ovary Syndrome Undergoing ICSI Using GnRH Antagonist Protocol
Cairo University
PCOS GnRH Antagonist and GnRH Agonist IVF/ICSI Cycles · IVF Outcomes
Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF Outcomes
Nesta Clinic
IVF · Fertility Issues · Infertility
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
Novartis Pharmaceuticals
Metastatic Neuroendocrine Prostate Cancer
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
University of Washington
Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Locally Advanced Unresectable HER2-Negative Breast Carcinoma · Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma
APHP220667
Assistance Publique Hopitaux De Paris
IVF (In vitro fertilization) or ICSI (intracytoplasmic sperm injection) protocol with embryo transfer planned on the same cycle.
CTOR18001GZA
Ziekenhuis Aan De Stroom
Prostate cancer
Cardiometabolic Consequences of the Loss of Ovarian Function
University of Colorado, Denver
Menopause · Estrogen Deficiency · Aging · Adiposity
Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation
Bedaya Hospital
Infertility
Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer
Mayo Clinic
Oligometastatic Prostate Carcinoma · Prostate Adenocarcinoma
2022_0016
Centre Hospitalier Universitaire De Lille
Polycystic ovarian
Breast Cancer & Antiestrogenic Therapy & Brain
International Research Training Group 2804
Breast Cancer Female · Healthy Female · Menopause · Anti-estrogenic Therapy
Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment
Nanjing University
Infertility, Female · Luteinizing Hormone (LH)
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
Eli Lilly and Company
Prostatic Neoplasms
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Hoffmann-La Roche
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
IBMR43
Instituto Bernabeu S.L.
Women undergoing ovarian stimulation for oocyte donation.
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT
Novartis Pharmaceuticals
Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger
Embryolab Fertility Clinic
Ovarian Stimulation · Human Chorionic Gonadotropin · Oocyte Donors
Recall by Genotype: Neuropeptide Stimulation
Stephanie B. Seminara, MD
Reproductive Disorder
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
Dana-Farber Cancer Institute
Breast Cancer · Early-stage Breast Cancer · High Risk Breast Carcinoma
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Prostate Cancer
Contributions to Hypertension With Androgen Deprivation Therapy
University of Colorado, Denver
Androgen Deprivation Therapy · Prostate Cancer · Hypertension · Autonomic Dysfunction
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche
Metastatic Breast Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT
Tam Anh TP. Ho Chi Minh General Hospital
Diminished Ovarian Reserve
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
Fudan University
Breast Cancer
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies
Bayer
Biochemically Recurrent Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Ovarian Stimulation With FSH Alone Versus FSH Plus GnRH Antagonist in an Oocyte Donor/Recipient Programme
National and Kapodistrian University of Athens
Premature Luteinisation · Progesterone Elevation
Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone
CRG UZ Brussel
Oocyte Donors · Oocyte Donation
Adenomyosis and ART
Azienda Ospedaliero-Universitaria di Modena
Adenomyosis
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
Royal College of Surgeons, Ireland
Hypogonadism, Male · Testosterone Deficiency · Prostate Cancer · Androgen Deficiency
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations
Rana McKay, MD
Prostate Cancer · BRCA1 Mutation · BRCA2 Mutation · Prostatic Adenocarcinoma
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
National Taiwan University Hospital
Premenopausal Breast Cancer · Metastatic Breast Cancer · ER Positive Breast Cancer
EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.
Institut Mutualiste Montsouris
Prostate Cancer · Androgen Deprivation Therapy
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Prostate Medication, Metabolism and Gut Microbiota
Turku University Hospital
Prostatic Hyperplasia · Prostate Cancer
Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve
Tanta University
Intracytoplasmic Sperm Injection · GnRH Agonist · Infertility · Ovarian Reserve
Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates
Shaare Zedek Medical Center
Luteal Phase Support
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer
Changhai Hospital
Treatment
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
Genentech, Inc.
Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
Effect of GH on the Blastocyst Euploid Rate in AMA Patients
ShangHai Ji Ai Genetics & IVF Institute
Preimplantation Genetic Testing · Growth Hormone · Age, Parental
Trifecta Research Study
Axial Therapeutic Research
PTSD - Post Traumatic Stress Disorder · Cognitive Dysfunction · Brain Injury · Depression - Major Depressive Disorder
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
Hoffmann-La Roche
Locally Advanced or Metastatic Breast Cancer
Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)
MedSIR
Metastatic Breast Cancer · Advanced Breast Cancer · Luminal Breast Cancer · HER2-negative Breast Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients
Xiaojun Chen
Atypical Endometrial Hyperplasia · Progesterone Resistance · Obesity
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
Xiaojun Chen
Endometrial Neoplasms · Atypical Endometrial Hyperplasia · Progesterone Resistance · Obesity
Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis
University Hospital, Toulouse
Adenomyosis
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
University Hospital, Ghent
Ovarian Reserve · Poor Responders · IVF
Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases
Zhujiang Hospital
Prostate Cancer With ≤10 Bone Metastases
Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HH
Huashan Hospital
Hypogonadotropic Hypogonadism
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)
University of Colorado, Denver
Menopause · Estrogen Deficiency · Women · Aging
A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
Hoffmann-La Roche
Ovarian Cancer
Dual Trigger for Elective Fertility Preservation
Fundación Santiago Dexeus Font
Infertility
A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer
Novartis Pharmaceuticals
Prostate Cancer Metastatic
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Hoffmann-La Roche
Early Breast Cancer
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)
AstraZeneca
ER-Positive HER2-Negative Breast Cancer
GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes
Tehran University of Medical Sciences
Polycystic Ovary Syndrome · Infertility, Female
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
University of Michigan Rogel Cancer Center
Prostate Cancer · Castrate Sensitive Prostate Cancer · Oligometastatic Disease
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts
Georgetown University
Breast Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer
Endocyte
Prostatic Neoplasms, Castration-Resistant
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
Hopital Foch
Endometriosis · Adenomyosis · Infertility, Female
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer
Bayer
Prostatic Neoplasms
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer
Zhujiang Hospital
High-Risk and Oligometastatic Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease
AstraZeneca
ER-Positive HER2-Negative Breast Cancer
The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Prostatectomy · Oligometastatic Prostate Cancer · Abiraterone
Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study
ShangHai Ji Ai Genetics & IVF Institute
Growth Hormone · Advanced Maternal Age · PGT-A
Goserline Acetate VS Dienogest in Endometriosi
Mansoura University
Endometriosis
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
Hoffmann-La Roche
Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer
Janssen Pharmaceutica N.V., Belgium
Prostatic Neoplasms
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.
Pfizer
Breast Neoplasms
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
Hoffmann-La Roche
Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
Spanish Breast Cancer Research Group
Early Breast Cancer
Skeletal Health and Bone Marrow Composition Among Youth
Amy DiVasta, MD
Gender Dysphoria in Children · Puberty · Bone Development
GnRH Therapy on Cognition in Down Syndrome
Nelly Pitteloud
Down Syndrome · Cognitive Decline · Alzheimer Disease, Early Onset · Olfaction Disorders
Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer.
University College, London
Adenomyosis
Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer
UNICANCER
Cancer Metastatic
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A
ShangHai Ji Ai Genetics & IVF Institute
Preimplantation Genetic Testing · Progestin-primed Ovarian Stimulation · Euploid Rate · GnRH Antagonist
GnRH Agonist for Luteal Phase Support.
Shaare Zedek Medical Center
Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF Cycles
Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response
ShangHai Ji Ai Genetics & IVF Institute
IVF · GnRH Antagonist · PPOS
INTREPId (INTermediate Risk Erection PreservatIon Trial)
Brigham and Women's Hospital
Prostate Cancer
Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome
Royan Institute
Polycystic Ovary Syndrome
Prolonged Protocol of Early Follicular or Mid Luteal Phase
Second Affiliated Hospital of Wenzhou Medical University
IVF
Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT
Dana-Farber Cancer Institute
Prostate Cancer
A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma
Janssen Pharmaceutical K.K.
Salivary Gland Neoplasms
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
University of Sydney
Prostate Cancer
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
Memorial Sloan Kettering Cancer Center
Metastatic Prostate Cancer
Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Sleep Restriction
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients
Wonju Severance Christian Hospital
Prostatic Neoplasms
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Cardiovascular Events in GnRH Agonist vs. Antagonist
Rabin Medical Center
Hormone Sensitive Prostate Cancer · Prostate Cancer · Cardiac Event
Effects of Co-treatment on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure
Universiti Kebangsaan Malaysia Medical Centre
Miscarriage, Recurrent
CARLHA-2_AN OPEN LABEL, RANDOMIZED, PHASE III STUDY EVALUATING THE EFFICACY OF ACOMBINATION OF APALUTAMIDE WITH RADIOTHERAPY AND LHRH AGONIST IN HIGH-RISK POST-PROSTATECTOMY BIOCHEMICALLY RELAPSED PROSTATE CANCER PATIENTS
Unicancer
High-risk biochemically-relapsed prostate adenocarcinoma following radical prostatectomy.
Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer
University of Chicago
Breast Cancer · Breast Cancer Female · HER2-positive Breast Cancer · Breast Cancer Stage II
Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy
SOLTI Breast Cancer Research Group
Breast Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients
UNICANCER
Breast Cancer Stage IV · Radiotherapy · Surgery
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
NRG Oncology
Prostate Adenocarcinoma · Stage IIC Prostate Cancer AJCC v8 · Stage III Prostate Cancer AJCC v8 · Stage IIIA Prostate Cancer AJCC v8
BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH
424 General Military Hospital
Endometriosis · Bone Density · Muscle · Bone Metabolism
Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis
European Institute of Oncology
Oligometastatic Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
Fundacion Dexeus
Infertility · IVF · Preimplantation Diagnosis
Bioenergetic Effects of Aging and Menopause (BEAM)
University of Colorado, Denver
Menopause · Obesity, Abdominal · Aging · Weight Gain
An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Astellas (Beijing) Pharmaceutical R&D Co., Ltd.
Metastatic Hormone Sensitive Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
ETOP IBCSG Partners Foundation
Breast Cancer Recurrent
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders
Royan Institute
Assisted Reproductive Techniques
Pulsatile Gonadotropin-releasing Hormone for Infertility in Non-obese Patients With Polycystic Ovary Syndrome
RenJi Hospital
Polycystic Ovary Syndrome · Infertility · Ovulation Disorder
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
Stephanie B. Seminara, MD
Hypogonadotropic Hypogonadism
Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)
Ferring Pharmaceuticals
Infertility, Female
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
RTOG Foundation, Inc.
Prostate Cancer
The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer
Turku University Hospital
Prostate Cancer
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
Jonsson Comprehensive Cancer Center
PSA Level Greater Than 0.03 · PSA Progression · Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7 · Stage II Prostate Adenocarcinoma AJCC v7
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Prostate Boost Irradiation With Stereotactic Body RT (SBRT)
Juravinski Cancer Center
Prostate Cancer
To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment
Peking University Third Hospital
Sterility
FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer
Fondazione Sandro Pitigliani
Breast Cancer
Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia
Seattle Institute for Biomedical and Clinical Research
Metastatic Prostate Cancer · Androgen Deprivation Therapy
Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer
University of Chicago
Breast Cancer · Breast Cancer Stage II · Breast Cancer Stage III
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Prostate Cancer · Stage IV Prostate Cancer · Advanced Prostate Cancer · Adenocarcinoma of the Prostate
Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer
University Hospital Sestre Milosrdnice
Prostate Cancer
Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment
Cairo University
Invitro Fertilization
Comparative Study Between ICSI Results in Transvaginal Ultrasound Guided Embryo Transfer and Transabdominal Ultrasound Guided Embryo Transfer
Cairo University
Invitro Fertilization
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
City of Hope Medical Center
Prostate Adenocarcinoma
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Prostate Cancer
A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients
Sun Yat-sen University
Breast Cancer
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
West China Second University Hospital
Endometrial Cancer · Atypical Endometrial Hyperplasia
Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET
Cairo University
Infertility
Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility
Lebanese University
Female Infertility · Female Infertility Due to Ovulatory Disorder · Premature Ovarian Failure · Polycystic Ovary Syndrome
Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders)
Ginegorama S.L.
Ovulation Induction · In Vitro Fertilization (IVF) · Infertility, Female · Oocytes
DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore
IVI Madrid
Infertility, Female
Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome
Yale University
Polycystic Ovary Syndrome · Hypertension
Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis
Centre for Endocrinology and Reproductive Medicine, Italy
Uterine Adenomyosis · Recurrent Implantation Failure · Menstrual Pain
EORTC-1532-GUCG: A phase 2 Randomized Open-Label Study of Oral darolutamide (ODM-201) vs. androgen deprivation therapy (ADT) with LHRH agonists or antagonist in Men with Hormone Naive Prostate Cancer.
European Organisation For Research And Treatment Of Cancer
Hormone Naive Prostate Cancer
Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response
Riyadh Fertility and Reproductive Health center
Infertility, Female
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)
Dana-Farber Cancer Institute
Prostate Cancer
A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
Genentech, Inc.
Breast Cancer
Administration of Kisspeptin in Patients With Hyperprolactinemia
Massachusetts General Hospital
Hyperprolactinemia · Hypogonadism
Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer
M.D. Anderson Cancer Center
Prostate Adenocarcinoma · Stage IIB Prostate Cancer AJCC v8 · Stage IIC Prostate Cancer AJCC v8 · Stage IIIA Prostate Cancer AJCC v8
Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Prostate Cancer
1414-ROG-GUCG
Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer European Organi
very high risk localized or locally advanced prostate cancer
Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer
Kyowa Kirin Co., Ltd.
Advanced or Recurrent Breast Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Effect of ADT on PSMA-PET.
Turku University Hospital
Prostate Cancer
Effects of Clomiphene Citrate Ovulation Induction on Frozen Embryo Transfer
ShangHai Ji Ai Genetics & IVF Institute
Infertility, Female · Clomiphene Citrate
Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol
Cairo University
Invitro Fertilization
Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer
Kansas State University
Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients
Ipsen
Prostate Cancer
A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants
Takeda
Central Precocious Puberty
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
Rutgers, The State University of New Jersey
Stage II Prostate Adenocarcinoma · Stage III Prostate Adenocarcinoma
Hormonal Mechanisms of Sleep Restriction - Axis Study
Peter y. Liu
Sleep Restriction
The Relation of GnRH Treatment to QTc Interval in Transgender Females
University of California, San Francisco
Gender Dysphoria
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Northwestern University
Castration-Resistant Prostatic Cancer · Metastatic Prostate Carcinoma · Recurrent Prostate Carcinoma · Stage IV Prostate Cancer
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Alliance Foundation Trials, LLC.
Prostate Cancer
Random-start Ovarian Stimulation in Egg-donors (ROSE)
Instituto Bernabeu
Infertility
Effects of SNP of GnRH Receptor Genes in IVF Patients
Miao benyu
Infertility, Female
Preventive Application of GnRH Antagonist on Early OHSS
First Affiliated Hospital, Sun Yat-Sen University
Ovarian Hyperstimulation Syndrome · GnRH Antagonist · Aspirin · Vascular Endothelial Growth Factor
Different routes of progesterone administration for sustaining implantation in in vitro fertilisation patients: impact on pregnancy and live birth rates
One Day Medical Center srl
Luteal phase supplementation in assisted reproduction
Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer
Assistance Publique - Hôpitaux de Paris
Cancer · Toxicity Due to Chemotherapy · Sarcoma · Osteosarcoma
Follicular Steroid Genesis in Controlled Ovarian Stimulation
Instituto Valenciano de Infertilidad, IVI VALENCIA
Infertility · Controlled Ovarian Hyperstimulation
Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI
Minia University
Infertility Indicated for ICSI
Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles
Cairo University
Assisted Reproduction
Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization
New Hope Fertility Center
Infertility
Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study
Sheba Medical Center
Embryo Transfer · Luteal Support
Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization
The First Affiliated Hospital of Zhengzhou University
Clinical Pregnancy Rate · Ovulation Induction · IVF
Reprometabolic Syndrome Mediates Subfertility in Obesity
University of Colorado, Denver
Obesity · Infertility · Hypogonadotropic Hypogonadotropism · Hyperinsulinemia
A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
Samsung Medical Center
Metastatic Breast Cancer
Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)
Chinese University of Hong Kong
Prostate Cancer
Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases
Ajjai Alva, MD
Prostate Cancer · Bone Metastases · Prostate Neoplasms
NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer
Midwestern Regional Medical Center
Breast Neoplasms
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Astellas Pharma Global Development, Inc.
Metastatic Hormone Sensitive Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist
Cairo University
Infertility
Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success
Cairo University
Reproductive Techniques, Assisted
Effect of Shorten Gonadotropin-releasing Hormone Agonist Therapy on the Outcome of in Vitro Fertilization-Embryo Transfer in Patients With Endometriosis
The First Affiliated Hospital of Zhengzhou University
Clinical Pregnancy Rate
Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
Peking Union Medical College Hospital
Hypogonadotropic Hypogonadism
A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
Merck KGaA, Darmstadt, Germany
Polycystic Ovary Syndrome
Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer
University of California, San Francisco
Prostatic Neoplasms · Pelvic Nodal
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient
Sir Mortimer B. Davis - Jewish General Hospital
Prostate Cancer
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
Aragon Pharmaceuticals, Inc.
Prostatic Neoplasms
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
University of Colorado, Denver
Adenocarcinoma of the Prostate · Recurrent Prostate Cancer · Stage III Prostate Cancer · Stage IV Prostate Cancer
Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer
Tianjin Medical University Cancer Institute and Hospital
Stage III Prostate Cancer
Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer
Tianjin Medical University Cancer Institute and Hospital
Stage IV Prostate Cancer
GnRH for Luteal Support in IVF/ICSI/FET Cycles
University Reproductive Associates
Infertility
Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone.
Ipsen
Prostate Cancer
Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists
Rabin Medical Center
Prostatic Neoplasms · Cardiovascular Diseases
Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty
Region Örebro County
Puberty, Precocious
Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)
Eugonia
Ovarian Hyperstimulation Syndrome
Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males
Lund University
Hypogonadism, Male
IVF Treatment in Women With Immature Oocytes in Previous Cycle
Sheba Medical Center
Infertility
The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles
Cairo University
Invitro Fertilization
A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Genentech, Inc.
Breast Cancer
Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Prostate Cancer
Dual Triggering in Patients With a High Immature Oocyte Rate
IVI Madrid
INFERTILITY
Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures
Rambam Health Care Campus
Infertility
Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy
Janssen Research & Development, LLC
Prostatic Neoplasms
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
Hôpital Jean Verdier
Fertility Preservation · Breast Cancer
Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.
Ferring Pharmaceuticals
Advanced Prostate Cancer
Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women
University of Colorado, Denver
Obesity · Fertility
Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)
Universität des Saarlandes
Prostate Cancer
Neuropeptides in Human Reproduction
Massachusetts General Hospital
Hypogonadotropic Hypogonadism
LutrePulse Hypogonadotropic Hypogonadism
Ferring Pharmaceuticals
Primary Amenorrhea With Hypogonadotropic Hypogonadism
AMH Levels Change During Treatment With GnRh Agonist
University Magna Graecia
Uterine Fibroids · Endometriosis · Endometriosis of Uterus · Pelvic Pain
Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer
M.D. Anderson Cancer Center
Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF
Bioroma
Female Infertility · Poor Responder
A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse
UNICANCER
Adenocarcinoma of Prostate · Progression of Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders
Huang Rui
Infertility
LH Response to GnRH Test in Prepubescent Girls Under 6 Years
University of Aarhus
Precocious Puberty
Evaluation of Granulosa Cells Function After IVF Protocols
Hospital de Clinicas de Porto Alegre
Infertility · In Vitro Fertilization Protocols
Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel
Merck KGaA, Darmstadt, Germany
Luteal Hormone Supplementation in In-vitro Fertilization · Embryo Transfer
Kisspeptin in the Evaluation of Delayed Puberty
Massachusetts General Hospital
Delayed Puberty · Kallmann Syndrome · Hypogonadotropic Hypogonadism · GnRH Deficiency
Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer
Fudan University
Breast Cancer Female
Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome
Aljazeera Hospital
OHSS
The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer
Aragon Pharmaceuticals, Inc.
Prostate Cancer
RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER
Istituto Clinico Humanitas
GnRH Trigger and Rescue Protocol
A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone
Centre of Experimental Medicine
Prostate Cancer
Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF
National and Kapodistrian University of Athens
Infertility
Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence
Centre for Endocrinology and Reproductive Medicine, Italy
Endometriosis
Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol
Cairo University
Invitro Fertilizaion
Efficacy Study Evaluating Chemotherapy in Prostate Cancer
Örebro University, Sweden
Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Females, Aging, Metabolism, and Exercise
University of Colorado, Denver
Obesity
Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles
Royan Institute
Infertility
Neoadjuvant Endocrine Therapy in Breast Cancer
Guangdong Provincial People's Hospital
Highly Endocrine Responsive Operable Breast Cancer
Degarelix Neo-Adjuvant Radical Prostatectomy Trial
University Health Network, Toronto
Prostate Cancer
Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients
GBG Forschungs GmbH
Male Breast Cancer
GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation
Nanjing University
Infertile High-risk Patients With Polycystic Ovaries
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Proton Collaborative Group
Prostate Cancer
Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation
Fundacion Dexeus
INFERTILITY · Fertility Preservation · Ovulation Induction · Vitrification
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Radiation Therapy Oncology Group
Prostate Cancer
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
H. Lee Moffitt Cancer Center and Research Institute
Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression
University Hospital, Basel, Switzerland
Female Infertility Due to Nonimplantation of Ovum · Complications Associated With Artificial Fertilization
Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation
UConn Health
Endometrial Receptivity · Ovarian Hyperstimulation Syndrome
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Proton Collaborative Group
Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients
AZ Jan Palfijn Gent
Infertility · PCOS
Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast Cancer
Affiliated Hospital to Academy of Military Medical Sciences
Breast Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate
University of Washington
Healthy
Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Prostate Cancer
FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Prostate Cancer
Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling
Massachusetts General Hospital
Hypogonadotropic Hypogonadism · Healthy Postmenopausal Women · Agonadism
Effect of ADT in Chinese Male With Prostate Cancer
Chinese University of Hong Kong
Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
Prostate Cancer
Estrogen Sensitivity and Ovulatory Dysfunction in Obesity
University of Colorado, Denver
Obesity · Infertility
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
Ipsen
Prostate Cancer
Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients
Instituto Valenciano de Infertilidad, IVI VALENCIA
Infertility
ITT4 Intratesticular Hormonal Milieu in Man (ITT4)
University of Washington
Healthy Males
CA 125 and VAS Pain Score Changes to Diagnose Endometriosis
University Magna Graecia
Pelvic Pain · Endometriosis
Comparative Study Between Minidose Long Protocol and Microdose Flare Protocol in Controlled Ovarian Hyperstimulation
Kasr El Aini Hospital
Infertility
Comparing Coasting by Withholding GnRH Agonist With GnRH Antagonist
Shin Kong Wu Ho-Su Memorial Hospital
In Vitro Fertilization
Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
University of Southern California
Prostate Cancer · Hormone-resistant Prostate Cancer · Recurrent Prostate Cancer · Stage IV Prostate Cancer
Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)
Ferring Pharmaceuticals
Infertility
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients
University Hospital Schleswig-Holstein
Infertility, Subfertility
Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist
Universitair Ziekenhuis Brussel
Reproductive Endocrinology · Fertility · Optimal Stimulation Protocol
Reproductive Hormonal Alterations in Obesity
University of Colorado, Denver
Obesity
Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism
Shanghai Jiao Tong University School of Medicine
Idiopathic Hypogonadotropic Hypogonadism
Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
Hospital de Niños R. Gutierrez de Buenos Aires
Central Precocious Puberty · Sexual Precocity
Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
Cougar Biotechnology, Inc.
Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
An additional rescue dose of GnRH antagonist administered the day before hCG trigger is effective to prevent ovarian hyperstimulation syndrome (OHSS) in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes
IAKENTRO (Greece)
Ovarian hyperstimulation syndrome (OHSS), ovarian stimulation, GnRH antagonist, IVF
Effect of Ultrasound Guided Embryo Transfer on Pregnancy Rates
Ain Shams Maternity Hospital
Infertility
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
Prostate Cancer
R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
National Cancer Institute (NCI)
Adenocarcinoma of the Prostate · Stage IV Prostate Cancer
Kisspeptin Administration in the Adult
Massachusetts General Hospital
Hypogonadotropic Hypogonadism · Kallmann Syndrome · GnRH Deficiency · PCOS
Metformin and gonadotrophin-releasing hormone (GnRH) antagonist co-treatment in in-vitro fertilisation (IVF) for women with polycystic ovary syndrome (PCOS)
Leeds Teaching Hospitals NHS Trust (UK)
Polycystic ovary syndrome
Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy
CHU de Quebec-Universite Laval
Prostate Cancer · Erectile Dysfunction · Lower Urinary Tract Symptoms
In Vitro Fertilization Outcomes of Two Treatment Protocols in Women With Polycystic Ovary Syndrome
Bulent Haydardedeoglu
PCOS GnRH Antagonist and GnRH Agonist IVF/ICSI Cycles
Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females
Ferring Pharmaceuticals
Infertility
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer
King Faisal Specialist Hospital & Research Center
Advanced Breast Cancer
Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment
University of Sao Paulo
Infertility
MENOPUR® Versus FOLLISTIM®
Ferring Pharmaceuticals
Infertility
Outcome of Two Protocols in Poor Responders in Assisted Reproductive Technology (ART) Cycle
Royan Institute
Infertility
Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET
Cairo University
Infertility
Clomifene Citrate as First Line Treatment in in Vitro Fertilization Cycles for Patients With Lower Ovarian Reserve
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Infertility
EXpression PRofile Endometrium Samples Study
Merck KGaA, Darmstadt, Germany
In Vitro Fertilization
PGL4001 Versus GnRH-agonist in Uterine Myomas
PregLem SA
Uterine Myomas
Urinary follicle stimulating hormone (FSH) usage in in vitro fertilisation (IVF) cycles
Bahceci Women Health Care Center (Turkey)
Primary infertility
Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer
Dana-Farber Cancer Institute
Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
Radiation Therapy Oncology Group
Prostate Cancer
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
Radiation Therapy Oncology Group
Prostate Cancer
A Study of Leuprolide to Treat Prostate Cancer
Abbott
Prostate Cancer
Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist
Yazd Research & Clinical Center for Infertility
Ovarian Stimulation
Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
ETOP IBCSG Partners Foundation
Breast Cancer · Fatigue · Sleep Disorders
A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age
Merck KGaA, Darmstadt, Germany
Infertility · Ovulation Induction
Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism
University of Aarhus
Hypogonadism
Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer
National Cancer Institute (NCI)
Adenocarcinoma of the Prostate · Recurrent Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer
The Methodist Hospital Research Institute
Prostatic Neoplasms
Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Ovarian Function · Preservation of Ovarian Function
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Alliance for Clinical Trials in Oncology
Prostate Cancer
Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy
Scandinavian Prostate Cancer Group
Prostate Cancer
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)
Organon and Co
Pregnancy · Neonates
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
Medical University of South Carolina
Prostate Cancer
Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation
Instituto Valenciano de Infertilidad, IVI VALENCIA
Infertility
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist
Ferring Pharmaceuticals
Sterility
Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)
Organon and Co
In Vitro Fertilization
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
ECOG-ACRIN Cancer Research Group
Metastatic Hormone-sensitive Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy
M.D. Anderson Cancer Center
Prostate Cancer
Duration of GnRH-analogue Downregulation and Pregnancy Rates
Aristotle University Of Thessaloniki
Infertility
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Radiation Therapy Oncology Group
Osteoporosis · Prostate Cancer
Effects of Testosterone and Fat Utilization
University of Colorado, Denver
Healthy · Volunteers
Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Breast Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Lutropin Alfa in Women at Risk of Poor Response
Merck KGaA, Darmstadt, Germany
Ovarian Stimulation
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
Radiation Therapy Oncology Group
Prostate Cancer
The efficacy of GnRH antagonists in cycles with mild ovarian hyperstimulation with recFSH in an intrauterine insemination program. A randomised placebo-controlled double-blinded investigator initiated study.
Isala Clinics, Sophia (Isala Klinieken Locatie Sophia) (Netherlands)
Intrauterine Insemination (IUI), Infertility, Subfertility
European Cooperative Study of Primary Systemic Therapy in Women with Operable Breast Cancer and T > 2 cm
Fondazione Michelangelo (Italy)
Early invasive unilateral breast cancer larger than 2 cm in diameter
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Metabolic Effects of Steroids in Obese Men
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Obesity · Insulin Resistance
Endometriosis Trial: Study of NBI-56418 in Endometriosis
Abbott
Endometriosis
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer
A.O.U. San Giovanni Battista di Torino, Italy
Pain · Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
Ferring Pharmaceuticals
InFertility
Reducing blood loss in laparoscopic and open myomectomy: a prospective randomised controlled trial comparing the benefit of triple tourniquets against gonadotropin releasing hormone (GnRH) analogues
Department of Health
Fibroids
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
M.D. Anderson Cancer Center
Metastatic Cancer · Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer
University of British Columbia
Prostate Cancer
Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
Mayo Clinic
Hypogonadism
Letrozole Treatment in Normal and GnRH Deficient Women
Massachusetts General Hospital
Healthy Volunteers
Administration of GnRH Antagonist to Oocyte Donation Recipients
Centro Ginecologia y Obstetricia.
Pregnancy · Embryo Implantation
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Alliance for Clinical Trials in Oncology
Metastatic Cancer · Prostate Cancer
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
ETOP IBCSG Partners Foundation
Estrogen Receptor Positive Breast Cancer · Progesterone Receptor Positive Tumor · Recurrent Breast Carcinoma · Stage IA Breast Cancer
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
ETOP IBCSG Partners Foundation
Breast Cancer
Premenopausal Endocrine Responsive Chemotherapy Trial
ETOP IBCSG Partners Foundation
Breast Cancer
Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Hypogonadism
Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer
University of Washington
Prostate Cancer
The Effects of Aging and Estrogen on the Pituitary
Massachusetts General Hospital
Healthy
Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Radiation Therapy Oncology Group
Prostate Cancer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.
US Department of Veterans Affairs
Hypogonadism · Spinal Cord Injury
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Memorial Sloan Kettering Cancer Center
Prostate · Cancer · Hormonal Cycling
Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Hypogonadism · Kallmann Syndrome
Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED)
Organon and Co
Pregnancy · Neonates
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
Alliance for Clinical Trials in Oncology
Prostate Cancer
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
Prostate Cancer
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
Prostate Cancer
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
Massachusetts General Hospital
Kallmann Syndrome · Idiopathic Hypogonadotropic Hypogonadism · GnRH Deficiency
A randomised trial comparing hormonal treatment versus combination of hormonal treatment and radiotherapy in locally advanced prostate cancer
Scandinavian Prostate Cancer Group (SPCG) (Sweden)
Local or locally advanced prostate cancer, pN0, M0
Investigating the Regulation of Reproductive Hormones in Adult Men
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Kallmann Syndrome · Hypogonadism · Gonadal Disorder
Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Neoplasm, Prostate
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
Massachusetts General Hospital
Kallmann Syndrome · Hypogonadotropic Hypogonadism · GnRH Deficiency
Pulsatile GnRH in Anovulatory Infertility
Massachusetts General Hospital
Hypogonadotropic Hypogonadism · Amenorrhea · Kallmann's Syndrome
Psychostimulant Abuse - Novel Treatment Approaches - 1
National Institute on Drug Abuse (NIDA)
Cocaine-Related Disorders
Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial
Rigshospitalet, Denmark
Infertility
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Gonadorelin (GnRH) is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.